AMAG Pharmaceuticals (AMAG) Upgraded to Buy by BidaskClub

Henrietta Strickland
April 16, 2018

On during the last trading session the stock decreased $0.6 or 2.76%, reaching $21.1.AMAG Pharmaceuticals, Inc. has volume of 507,668 shares. The specialty pharmaceutical company reported $0.10 EPS for the quarter, beating the Zacks' consensus estimate of ($0.58) by $0.68. The company has a market capitalization of $719.28, a P/E ratio of 100.48 and a beta of 0.09. About 5.50 million shares traded. It has outperformed by 12.44% the S&P500.

NASDAQ:AMAG traded down $0.60 on Friday, reaching $21.10. Prelude Capital Management Ltd Llc holds 0% or 559 shs.

Jones Collombin Investment Counsel Inc increased Csx Corp (NYSE:CSX) stake by 9,430 shares to 57,045 valued at $3.14 million in 2017Q4.

AMAG Pharmaceuticals (NASDAQ:AMAG) was upgraded by stock analysts at BidaskClub from a "hold" rating to a "buy" rating in a report issued on Friday, April 6th. Meanwhile, AMAG has a wider range of statistics for different time periods, instigating from Perf Week performance pitched 0.95% during the last five trading sessions repeatedly. AMAG Pharmaceuticals has a fifty-two week low of $11.93 and a fifty-two week high of $24.85. The stock underperformed the S&P500 by 27.80%.

Since February 16, 2018, it had 0 insider buys, and 3 sales for $930,912 activity. 2,099 shares were sold by Friedman Stacey, worth $214,019. 602.87 million shares or 1.51% less from 612.12 million shares in 2017Q3 were reported. (NYSE:JPM) was sold by Lake Marianne on Saturday, January 13. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Microsoft Corporation had 170 analyst reports since July 22, 2015 according to SRatingsIntel. This rating is on a scale of 1 to 5. Argus Research maintained the shares of JPM in report on Wednesday, October 14 with "Buy" rating. The rating was initiated by Citigroup on Thursday, January 19 with "Buy". The stock of JPMorgan Chase & Co.

US stocks closed in the red on Wednesday, as worries about geopolitical developments deflated the buying mood on Wall Street. The firm has "Buy" rating given on Friday, March 2 by UBS.

Investors sentiment increased to 0.8 in Q4 2017. It's down -0.10, from 1.02 in 2017Q3. It increased, as 66 investors sold CSX shares while 324 reduced holdings. 50 rose positions while 24 funds took positions. Camber Capital Mgmt Limited Liability stated it has 1.72% in AMAG Pharmaceuticals, Inc. Shares are now at -7.83% over the past year and year to date performance pointed at 60.00%. Citigroup holds 105,674 shares or 0% of its portfolio. (NYSE:JPM) for 16.02 million shares. Mufg Americas Corporation owns 27,755 shares. First Tru Advisors Limited Partnership has invested 0.05% in CSX Corporation (NASDAQ:CSX). Sei Investments Company reported 4.74M shares. The company has a Return on Assets (ROA) of -9.30%. Kj Harrison Prns owns 46,714 shares. Piermont reported 0.06% stake. Gamco Investors Incorporated Et Al holds 155,267 shares or 0.08% of its portfolio. Allstate accumulated 2,986 shares.

Since February 23, 2018, it had 0 buys, and 1 sale for $16,016 activity. City Holding owns 12,218 shares or 0.21% of their United States portfolio. Municipal Employees Retirement System of MI lifted its stake in AMAG Pharmaceuticals by 58.8% in the 3rd quarter. Therefore 21% are positive. It also provides HR outsourcing services, such as Paychex HR solutions comprising payroll, employer compliance, HR and employee benefits administration, risk management outsourcing, and the on-site availability of a professionally trained HR representative; and retirement services administration, including plan implementation, ongoing compliance with government regulations, employee and employer reporting, participant and employer online access, electronic funds transfer, and other administrative services. On Wednesday, February 14 the firm has "Hold" rating by Cantor Fitzgerald given. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has declined 16.25% since April 12, 2017 and is downtrending. (NASDAQ:AMAG) earned "Market Perform" rating by Raymond James on Wednesday, May 4. The stock rating was maintained by Cantor Fitzgerald with "Hold" on Thursday, February 1. On Friday, November 3 the firm has "Overweight" rating by Morgan Stanley given. Susquehanna maintained CSX Corporation (NASDAQ:CSX) rating on Friday, March 2. The firm has "Buy" rating given on Thursday, October 27 by Needham. AMAG Pharmaceuticals has a consensus rating of "Hold" and a consensus target price of $23.91. Barclays Capital initiated the shares of PAYX in report on Tuesday, December 20 with "Equal Weight" rating. Comerica State Bank stated it has 0% of its capital in AMAG Pharmaceuticals, Inc.

In total 8 analysts cover Amag Pharmaceuticals (NASDAQ:AMAG). Also, the number of funds holding Cyanotech Corp in top ten holdings was flat from 0 to 0 for the same number.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER